TopFunds

Colgate-Palmolive

NYSE: CL

Stock price

96.38 USD

(+0%) TODAY

Household ProductsHousehold & Personal Products
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.5
2.7
2.3
2.8
2.8
3.1
2.6
2.1
2.8
3.5
2.6
5.6%
02Free cash flow per share
2.5
2.8
2.8
3
3.2
3.9
3.3
2.2
3.7
4.3
4.5
6.1%
03Dividends per share
1.5
1.5
1.6
1.7
1.7
1.8
1.8
1.9
1.9
2
2.1
3.2%
04Dividends payout, %
1.1%
61.8%
75.5%
66.3%
68.2%
55.7%
77.5%
94.7%
76%
61.9%
85.5%
54.9%
PROFIT AND LOSS STATEMENT
05Revenue
$ 16,034
$ 15,195
$ 15,454
$ 15,544
$ 15,693
$ 16,471
$ 17,421
$ 17,967
$ 19,457
$ 20,101
$ 20,382
2.4%
06% Change
-
(5.2)%
1.7%
0.6%
1%
5%
5.8%
3.1%
8.3%
3.3%
1.4%
2.4%
07Cost of revenue
(6,664)
(6,063)
(6,131)
(6,338)
(6,416)
(6,538)
(7,128)
(7,817)
(8,206)
(7,995)
(8,131)
2%
08Gross profit
9,370
9,132
9,323
9,206
9,277
9,933
10,293
10,150
11,251
12,106
12,251
2.7%
09% Margin
58.4%
60.1%
60.3%
59.2%
59.1%
60.3%
59.1%
56.5%
57.8%
60.2%
60.1%
59.2% A
10Operating expenses
(5,400)
(5,172)
(5,314)
(5,356)
(5,515)
(6,022)
(6,407)
(6,565)
(7,120)
(7,723)
(8,945)
5.2%
11% of Revenue
(33.7)%
(34)%
(34.4)%
(34.5)%
(35.1)%
(36.6)%
(36.8)%
(36.5)%
(36.6)%
(38.4)%
(43.9)%
(36.4)% A
12Operating Income
3,970
3,960
4,009
3,850
3,762
3,911
3,886
3,585
4,131
4,383
3,306
(1.8)%
13Income tax expense
(1,215)
(1,152)
(1,313)
(906)
(774)
(787)
(749)
(693)
(937)
(907)
(798)
(4.1)%
14Net Income
1,384
2,441
2,024
2,400
2,367
2,695
2,166
1,785
2,300
2,889
2,132
4.4%
15% Margin
8.6%
16.1%
13.1%
15.4%
15.1%
16.4%
12.4%
9.9%
11.8%
14.4%
10.5%
13.1% A
16Shares Outstanding
909,700
898,400
887,800
873,000
861,100
859,300
848,300
838,800
829,200
822,500
811,100
(1.1)%
17EPS Basic
1.5
2.7
2.3
2.8
2.8
3.2
2.6
2.1
2.8
3.5
2.6
5.6%
18EPS Diluted
1.5
2.7
2.3
2.8
2.8
3.1
2.6
2.1
2.8
3.5
2.6
5.6%
19EBITDA
3,345
4,330
4,115
4,168
4,012
4,346
3,760
3,372
4,246
4,853
4,868
3.8%
% Margin
20.9%
28.5%
26.6%
26.8%
25.6%
26.4%
21.6%
18.8%
21.8%
24.1%
23.9%
24.1% A
20Net Interest Income (expense)
(26)
(99)
(102)
(143)
(145)
(141)
(100)
(153)
(232)
(225)
(192)
22.1%
21Net Debt / EBITDA
1.7
1.2
1.2
1.4
1.9
1.7
1.9
2.5
1.9
1.5
1.5
1.7 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
970
1,315
1,535
726
883
888
832
775
966
1,096
1,288
2.9%
23Short-term investments
-
-
-
-
-
-
-
-
-
160
-
-
24Accounts receivable
1,427
1,411
1,480
1,400
1,440
1,264
1,297
1,504
1,586
1,521
1,675
1.6%
25Other current assets
807
441
403
417
456
513
576
760
793
553
714
(1.2)%
26Inventory
1,180
1,171
1,221
1,250
1,400
1,673
1,692
2,074
1,934
1,987
2,032
5.6%
27Total Current Assets
4,384
4,338
4,639
3,793
4,179
4,338
4,397
5,113
5,279
5,317
5,709
2.7%
Non-Current Assets
28Net property, plant & equipment
3,796
3,840
4,072
3,881
3,750
3,716
3,730
4,307
4,582
4,422
4,660
2.1%
29Long-term investments
-
-
-
-
-
-
-
-
-
81
-
-
30Other non-current assets
3,778
3,945
3,965
4,487
7,105
7,866
6,913
6,311
6,532
6,226
5,961
4.7%
31Total Non-Current Assets
7,574
7,785
8,037
8,368
10,855
11,582
10,643
10,618
11,114
10,729
10,621
3.4%
Total Assets
11,958
12,123
12,676
12,161
15,034
15,920
15,040
15,731
16,393
16,046
16,330
3.2%
LIABILITIES
Current Liabilities
32Accounts payable
1,110
1,124
1,212
1,222
1,237
1,393
1,479
1,551
1,698
1,805
2,089
6.5%
33Short-term debt
302
13
11
12
659
404
188
133
425
767
1,235
15.1%
34Other current liabilities
2,122
2,168
2,185
2,107
2,142
2,607
2,384
2,320
2,618
3,187
3,529
5.2%
35Total Current Liabilities
3,534
3,305
3,408
3,341
4,038
4,404
4,051
4,004
4,741
5,759
6,853
6.9%
Non-Current Liabilities
36Long-term debt
6,246
6,520
6,566
6,354
7,824
7,810
7,645
9,138
8,639
7,745
7,319
1.6%
37Other non-current liabilities
2,199
2,281
2,459
2,269
2,614
2,605
2,373
1,783
2,056
1,998
1,793
(2)%
38Total Non-Current Liabilities
8,445
8,801
9,025
8,623
10,438
10,415
10,018
10,921
10,695
9,743
9,112
0.8%
39Total Liabilities
12,002
12,106
12,433
11,964
14,476
14,819
14,069
14,925
15,436
15,502
15,965
2.9%
SHAREHOLDERS` EQUITY
40Common stock
1,466
1,466
1,466
1,466
1,466
1,466
1,466
1,466
1,466
1,466
1,466
-
41Retained earnings / (deficit)
18,861
19,922
20,531
21,615
22,501
23,699
24,350
24,573
25,289
26,145
26,595
3.5%
42Accumulated other comprehensive income / (loss)
(3,950)
(4,180)
(3,855)
(4,188)
(4,273)
(4,345)
(4,386)
(4,055)
(3,937)
(4,222)
(3,879)
(0.2)%
43Noncontrolling interests
255
260
303
299
441
358
362
405
348
332
311
2%
44Total shareholders' equity
(44)
17
243
197
558
1,101
971
806
957
544
365
-
45Total Liabilities and shareholders' Equity
11,958
12,123
12,676
12,161
15,034
15,920
15,040
15,731
16,393
16,046
16,330
3.2%
46Total Debt
6,548
6,533
6,577
6,366
8,483
8,214
7,833
9,271
9,064
8,512
8,554
2.7%
47Net Debt
5,578
5,218
5,042
5,640
7,600
7,326
7,001
8,496
8,098
7,416
7,266
2.7%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,384
2,441
2,024
2,400
2,367
2,695
2,166
1,785
2,300
2,889
2,132
4.4%
49Depreciation & amortization
449
443
475
511
519
539
556
545
567
605
630
3.4%
50Share-based compensation expense
125
123
127
109
100
107
135
125
122
135
-
-
51Changes in working capital and other assets
991
134
428
36
147
378
468
101
756
478
1,436
3.8%
52Net cash flows from operating activities
2,949
3,141
3,054
3,056
3,133
3,719
3,325
2,556
3,745
4,107
4,198
3.6%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(691)
(593)
(553)
(436)
(335)
(410)
(567)
(696)
(705)
(561)
(564)
(2)%
54Purchases of investments / marketable securities
(742)
(336)
(347)
(169)
(184)
(143)
(141)
(470)
(506)
(574)
(698)
(0.6)%
55Proceeds from maturities of marketable securities
599
378
391
156
131
124
141
322
502
564
752
2.3%
56Other investing activities
149
52
38
(721)
(1,711)
(449)
(25)
(757)
(33)
37
(307)
-
57Net cash flows from investing activities
(685)
(499)
(471)
(1,170)
(2,099)
(878)
(592)
(1,601)
(742)
(534)
(817)
1.8%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(1,551)
(1,335)
(1,399)
(1,238)
(1,202)
(602)
(1,320)
(1,308)
(1,128)
(1,739)
(1,109)
(3.3)%
59Dividends paid, net
(1,493)
(1,508)
(1,529)
(1,591)
(1,614)
(1,502)
(1,679)
(1,691)
(1,749)
(1,789)
(1,823)
2%
60Debt issuance (repayments), net
421
164
(29)
(179)
1,433
(564)
(175)
1,647
(314)
(408)
(456)
-
61Other financing activities
347
446
507
329
513
(152)
400
400
398
547
132
(9.2)%
62Net cash flows from financing activities
(2,276)
(2,233)
(2,450)
(2,679)
(870)
(2,820)
(2,774)
(952)
(2,793)
(3,389)
(3,256)
3.7%
63Increase (decrease) in cash and cash equivalents
(119)
345
220
(809)
157
5
(56)
(57)
191
130
192
-
64Cash and equivalents, ending balance
970
1,315
1,535
726
883
888
832
775
966
1,096
1,288
2.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
2,258
2,548
2,501
2,620
2,798
3,309
2,758
1,860
3,040
3,546
3,634
4.9%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Colgate-Palmolive (CL) financial statements and performance

Explore Colgate-Palmolive (CL) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.